Tradestie Institutional Equity Comparison Engine

GRAL vs GPCR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GRAL Overall Edge

GRAL Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to GRAIL, Inc. Common Stock (GRAL) driven by superior Valuation, Momentum & Technical while GPCR counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus GPCR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against GPCR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GRAL
GRAL 1.1x vs GPCR N/M Fwd P/E
Growth & Margin Winner GPCR
Op Margin -332.0% vs 0.0% ยท YoY +3.7% vs +0.0%
Momentum & Technical Winner GRAL
1Y +24.6% vs -46.9% ยท 52W Pos 51% vs 0%
Options & Structure Winner GPCR
BREAKDOWN (53rd %ile IV) vs UNCLASSIFIED (<1st %ile IV)
GRAL NASDAQ
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
1M Return -10.36%
1Y Return +24.57%
Forward P/E 1.1x
Unified AI Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0
GPCR NASDAQ
Structure Therapeutics Inc. American Depositary Shares
Pharmaceutical Preparations
$18.57
-7.15% 1D
Market Cap $1.4B
1M Return -11.91%
1Y Return -46.94%
Forward P/E N/M
Unified AI Score
41.2 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GRAL +24.57% GPCR -46.94% Spread: +73.86 pp (GRAL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GRAL TTM Op. Margin: -332.0% GPCR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GRAL vs GPCR. Trailing 12-month operating profitability (GRAL -332.0% vs GPCR 0.0%) and valuation multiples (GRAL 1.1x vs GPCR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GRAL (7) vs GPCR (3)
Institutional Metric GRAL GPCR Criterion Row Winner
Market Capitalization Scale $5.2B $1.4B Larger Scale GRAL
Trailing P/E Ratio Valuation 1.1x N/M Lower Multiple GRAL
Forward P/E Ratio Valuation 1.1x N/M Lower Multiple GRAL
Revenue Growth (YoY) Growth +3.7% +0.0% Higher Growth GRAL
Operating Margin (TTM) Profitability -332.0% 0.0% Higher Margin GPCR
Net Profit Margin Profitability -243.8% 0.0% Higher Margin GPCR
Return on Equity (ROE) Capital Efficiency -17.3% -20.2% Higher ROE GRAL
52-Week Range Position Momentum 51% ($42โ€“$166) 0% ($18โ€“$95) Stronger Trend GRAL
Beta / 30D Volatility Risk Regime 3.09ฮฒ ยท 99% Vol 1.37ฮฒ ยท 58% Vol Lower Realized Risk GPCR
Unified Institutional Score Composite Signal 54.5 / 100 (HOLD) 41.2 / 100 (SELL) Higher Composite GRAL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GRAL vs GPCR Buy Guide
GRAL BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live GRAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GPCR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live GPCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GRAL nor GPCR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.